Related Experiment Videos
Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand
Nathorn Chaiyakunapruk1, Olarik Asuphol, Teerapon Dhippayom
1Center of Pharmaceutical Outcomes Research (CPOR) Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences Pharmaceutical Care Research Unit, Naresuan University Buddhachinnaraj Hospital, Phitsanulok, Thailand. nui@u.washington.edu
Insights
Many patients, especially those using statins for primary prevention, do not require this medication. New generation statins like atorvastatin are often unnecessary unless specific low-density lipoprotein cholesterol goals are needed for secondary prevention.
Area of Science:
- Cardiology
- Pharmacology
- Health Services Research
Background:
- Statin therapy is widely prescribed for cardiovascular disease prevention.
- Understanding statin usage patterns is crucial for optimizing patient care and resource allocation.
Purpose of the Study:
- To analyze statin prescribing patterns in a tertiary care hospital.
- To evaluate the necessity of new-generation statins based on patient indications and lipid goals.
Main Methods:
- Retrospective cohort study of 2479 new statin users in Thailand.
- Indication assessment based on coronary heart disease (CHD) history and CHD-risk equivalents.
- Analysis of lipid profiles and achievement of low-density lipoprotein cholesterol (LDL-C) goals.
Main Results:
- 58% of statin users received them for primary prevention; all atorvastatin use in this group was deemed unnecessary.
- For secondary prevention aiming for LDL-C <130 mg/dL, 80% of atorvastatin users could switch to simvastatin.
- To achieve LDL-C <70 mg/dL, 58.6% of patients required atorvastatin, while 40.2% of simvastatin users met this goal.
Conclusions:
- A significant number of patients, particularly those on primary prevention, do not need statin therapy.
- Atorvastatin is largely unnecessary except for secondary prevention in patients needing intensive LDL-C reduction (<70 mg/dL).
- Findings suggest a need for hospital policies to ensure appropriate statin utilization.
Objectives:
To determine statin usage pattern and evaluate whether new generation statins are actually needed by the patients receiving them.
Methods:
This retrospective cohort included patients receiving first-time statins at a tertiary care hospital in Thailand. Using electronic medical records from 2005, its indication was determined based on history of coronary heart disease (CHD) and CHD-risk equivalents. The lipid profiles tested within 30 days prior to the first date of statins prescription were analysed. Each patient was assessed as to whether statin was needed based on low-density lipoprotein cholesterol (LDL-C) reduction capacity and lipid goals.
Results:
A total of 2479 first-time statin users was included. Ninety percent of the users received simvastatin, while 8% and 2% received atorvastatin and pravastatin respectively. More than half (58.0%) used statins for primary prevention, although all usage of atorvastatin was considered not needed. Considering the use of statin for secondary prevention to achieve the LDL-C goal of <130mg/dl (3.37mmol/l), more than 80% of atorvastatin users could be switched to simvastatin. Only 8% of simvastatin usage would not be able to achieve this target. When the LDL-C goal was <70mg/dl (1.81mmol/l), 40.2% simvastatin users was considered appropriate, while 58.6% needed atorvastatin to be prescribed.
Conclusion:
A substantial proportion of patients did not need statins therapy, particularly for primary prevention. In addition, atorvastatin use is mostly not needed except in patients requiring statins for secondary prevention to achieve the LDL-C goal of <70mg/dl (1.81mmol/l). The findings should prompt hospital policy makers to develop measures to ensure the proper use of statins in their clinical settings.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Therapeutic Drug Monitoring: Affecting Factors